Search hospitals > Illinois > Springfield
Memorial Medical Center
Claim this profileSpringfield, Illinois 62702
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Ovarian Cancer
435 reported clinical trials
4 medical researchers
Summary
Memorial Medical Center is a medical facility located in Springfield, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Ovarian Cancer and other specialties. Memorial Medical Center is involved with conducting 435 clinical trials across 533 conditions. There are 4 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Stephen Hazelrigg, MD, and Tony DeMartini, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Bryan A. FallerCrossroads Cancer Center6 years of reported clinical research
Expert in Lung Cancer
Expert in Breast Cancer
239 reported clinical trials
297 drugs studied
James L. WadeDecatur Memorial Hospital4 years of reported clinical research
Studies Breast Cancer
Studies Bladder Cancer
11 reported clinical trials
20 drugs studied
Stephen Hazelrigg, MDMemorial Medical Center8 years of reported clinical research
Studies Left Ventricular Dysfunction
Studies Stroke
2 reported clinical trials
2 drugs studied
Tony DeMartini, MDMemorial Medical Center4 years of reported clinical research
Studies Heart Attack
Studies Myocardial Infarction
1 reported clinical trial
1 drug studied
Clinical Trials running at Memorial Medical Center
Lung Cancer
Prostate Cancer
Esophageal cancer
Breast Cancer
Bladder Cancer
Cancer
Breast cancer
Pancreatic Cancer
Multiple Myeloma
Kidney Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Memorial Medical Center?
Memorial Medical Center is a medical facility located in Springfield, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Ovarian Cancer and other specialties. Memorial Medical Center is involved with conducting 435 clinical trials across 533 conditions. There are 4 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Stephen Hazelrigg, MD, and Tony DeMartini, MD.
Where is Memorial Medical Center located?
**Memorial Medical Center**
- **Address:** 701 N. First St., Springfield, IL 62781
- **Amenities:** Elevators, food services, free parking, patient waiting rooms, wheelchair accessibility.
Who should I call to ask about financial aid or insurance network?
**Memorial Medical Center Contact Information**
**Financial Assistance:**
- Patient Financial Services Department: 954-276-5501
- Eligibility Department: 954-276-5760
- Visit Admitting/registration areas in the main lobby of any acute care facility
- Eligibility Office Hours: Monday-Friday, 8 am to 4:30 pm
**Insurance:**
- For coverage-related questions, contact your insurance provider directly.
**Additional Assistance:**
- Customer Service Department: 989-720-2000
What insurance does Memorial Medical Center accept?
Memorial Medical Center accepts a variety of insurance plans such as Blue Cross Blue Shield, Cigna, Humana, Medicare, NM Medicaid, Presbyterian, TriCare, Western Sky, and United Health Care. MemorialCare Medical Group and Urgent Care accept major HMO, PPO, EPO health plans, Medicare, private indemnity, and supplemental insurance plans. Memorial Health and Memorial Healthcare System also support a broad spectrum of insurance options, including Commercial, ACA/Exchange, Medicare, Medicare Advantage, Medicaid, and provide a self-insured plan for businesses.
What awards or recognition has Memorial Medical Center received?
Memorial Medical Center, located in Springfield, Illinois, has been nationally recognized for its excellence in stroke care, earning the prestigious American Hospital Association's top national award for quality and safety. It holds accreditation from The Joint Commission and boasts Magnet recognition for nursing excellence. The hospital has a rich history of healthcare innovation since its founding in 1897.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.